The Global Antibiotic Research & Development Partnership (GARDP) is a joint initiative of Drugs for Neglected Diseases initiative (DNDi) and the World Health Organization (WHO). GARDP is a non-profit research and development initiative that develops new therapies for bacterial infections. The focus is on infections in which antimicrobial resistance (AMR) is already present or has emerged, or where adequate treatment is currently unavailable. It addresses, in particular, gaps in public health and takes measures for sustainable, equitable and affordable access into account. GARDP has four programs that develop treatments for different areas.